Due to the current situation the Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020.The Radboudumc Hypatia Tenure Track Grants aim to promote innovation in academic research by giving young, creative and talented researchers the opportunity to further develop their own research within the context of their research institute and within the strategic areas of Radboudumc. These unique and highly sought research positions offer a special opportunity to establish an independent research group in a specific topic.
For 2020, two positions are earmarked for RIHS and RIMLS, respectively. Therefore, Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in both institutes.
With the Hypatia Tenure Track Grants we intend to recruit talent from outside Radboudumc. In this respect candidates should not have had an employment relationship with Radboud University or Radboudumc in the last 3 years.
More information: link.
Related news items
Frank Walboomers 25-years work anniversary at Radboudumc17 September 2020
Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.read more
Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes17 September 2020
Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.read more
Annette Schenck appointed professor of Translational Genetics17 September 2020
Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.read more
Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients17 September 2020
Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.read more
Radboudumc does large-scale research on systemic sclerosis10 September 2020
In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.read more